Administration
Multi-line oncology administration sets
Primary, secondary and multi-line configurations with selected access, valve, filtration and light-protection routes.
Oncology infusion pathways
Bring the oncology fluid pathway together.
Start with the administration set or extension line, then review light-protected tubing, filtration, vial access, needle-free interfaces and closed-transfer requirements as one configuration-specific pathway.
Representative multi-line light-protected configuration
Administration sets Primary, secondary and multi-line routes
Oncology extension lines Light-protected and functional modules
Vial & needle-free access Interfaces reviewed within the pathway
CSTD reviewed separately No family-wide closed-system claim
One oncology product platform
Choose the part of the pathway you need to solve.
The products can be reviewed individually or as part of a complete customer-defined workflow. Exact availability, material, performance and market status remain REF-specific.
Filtered route
Light-protected filtered sets
A finished-line route with the filter position, tubing and interfaces confirmed by the selected product reference.
Flow control
Flow-regulated oncology sets
A configuration route combining a finished administration set with a defined flow-regulating component.
Extension
Oncology extension & secondary lines
Defined lengths, connections, branches, valves and filters arranged around the required oncology fluid path.
Vial access
Vial Adaptor
A vial-interface module for configuration review. Exact mating components and intended workflow must be defined.
Needle-free
Male Luer needle-free connector
A male-Luer access interface that may be reviewed with tubing, extension and vial-access components.
Combination
Vial-adaptor + needle-free combinations
Selected component combinations can be reviewed for a customer-defined workflow; this is not a CSTD status claim.
Development
CSTD development pathway
A separate system-development and validation route. Current oncology components are not presented as a verified complete CSTD.
Finished configuration examples
See how the selected parts become a complete line.
Real product photographs show the component and manufacturing routes. The catalog diagrams below make the finished arrangement easier to compare before you send your own reference.
ON.PRI.01 · Primary set · single access route 2500 mm catalog example. Exact tubing, material, interfaces and market status follow the selected REF.
Catalog p.26 → 
ON.PRI.02 · Primary set · dual access route 2500 mm catalog example. Exact tubing, material, interfaces and market status follow the selected REF.
Catalog p.26 → 
ON.PRI.03 · Primary set · four-access route 2500 mm catalog example. Exact tubing, material, interfaces and market status follow the selected REF.
Catalog p.26 → 
ON.SEC.01 · Secondary set · simple line 400 mm catalog example. Exact tubing, material, interfaces and market status follow the selected REF.
Catalog p.27 → 
ON.SEC.03 · Secondary set · NFV + filter route 450 mm catalog example. Exact tubing, material, interfaces and market status follow the selected REF.
Catalog p.27 → 
ON.SEC.05 · Secondary set · multi-access route 300 mm catalog example. Exact tubing, material, interfaces and market status follow the selected REF.
Catalog p.27 → Catalog boundary: these are reference configurations, not transferable performance claims. BQ+ confirms the exact drawing, tubing, filter, valve, packaging and destination-market status for the selected product reference.
Light-protected tubing architecture
Light protection starts with the tubing—not the colour alone.
For selected light-protected configurations, BQ+ uses a dual-layer co-extruded tubing route. The selected REF defines the layer materials, dimensions and applicable light-protection evidence.
Dual-layer co-extrusion route Two functional layers are formed in one controlled tubing architecture for selected configurations.
Configuration-defined materials Inner and outer layers, dimensions and interfaces are confirmed for the exact product.
Performance follows controlled evidence Wavelength range, light transmission, ageing and fluid-contact evidence require REF-level review.
Light-protected component choices
Keep the visible fluid-path components consistent.
Representative orange, amber and light-protected tubing choices are shown for easier selection. Colour identifies a product route; it is not evidence that every combination is available, approved or suitable.
Orange Y injection site ST103-OR Access position confirmed by the complete configuration.
Amber IV filter AFRM-0.2-HAM Filter selection and public performance follow the exact product evidence.
Orange roller clamp RC108 A representative handling component for selected light-protected routes.
Amber drip chamber A1 amber Chamber, venting and spike combination are confirmed by finished-set REF.
Light-protected tubing route Configuration-specific Tubing construction, dimensions and applicable evidence are confirmed by the selected REF.
Orange rotating male Luer lock MLL05-OR Connection type and compatibility are confirmed within the complete fluid-path configuration.
Orange male Luer lock MLL13-OR A second connector route for configurations requiring a different interface form.
Alternative amber drip chamber A4F-OR An additional chamber route; spike, venting and set compatibility follow the finished-set REF.
Configuration review
Five decisions turn the product collection into your pathway.
Send your existing specification, drawing, sample or catalog reference. BQ+ can prepare the closest controlled configuration for review.
CSTD boundary
Component capability and CSTD status are not the same claim.
BQ+ can review vial adaptors, male-Luer needle-free interfaces and other modules within oncology workflows. A verified CSTD requires a separately defined system and evidence package.
A CSTD development review must define:
- the complete system and every mating interface;
- preparation, transfer and disconnection sequence;
- containment, leakage and performance criteria;
- product-specific test evidence and regulatory assessment;
- approved labeling, intended use and market status.
Why this matters to you
BQ+ oncology sets, extension lines, vial adaptors and needle-free components are not presented here as a verified complete CSTD. The CSTD route remains a separate development pathway so the quotation and evidence package can match the actual product route.
FAQ
Questions buyers ask before requesting an oncology configuration.
Can BQ+ combine administration sets, extension lines and vial-access components?
They can be reviewed within one defined pathway, but the final combination, evidence and market status belong to the selected product references.
Does orange tubing prove a specific light-protection range?
No. Colour alone is not performance evidence. The wavelength range and light-transmission claim require the exact tubing construction and applicable controlled report.
Does BQ+ use dual-layer tubing?
BQ+ uses a dual-layer co-extruded tubing route for selected configurations. Public technical claims still require the controlled product record and specialist approval.
Are the products shown here a complete CSTD?
No. The CSTD development pathway is separately defined and does not transfer CSTD status to the administration sets, extension lines or individual interfaces shown on this page.